Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
M&A
Fierce Pharma
Vertex to pay $10B for Crinetics in its largest-ever deal
Vertex has scored its largest-ever transaction, agreeing to acquire Crinetics and two of its drugs that have combined peak sales potential of $5B.
Kevin Dunleavy
Jul 7, 2026 8:08am
Zimmer Biomet buys pain relief system from Pacira in $140M deal
Jul 1, 2026 10:58am
Fierce Pharma
Fosun Pharma plots global push, fueled by Alzheimer’s deals
Jun 25, 2026 7:00pm
Fierce Pharma
PwC projects continued growth for rest of 2026, fueled by M&A
Jun 17, 2026 5:00am
Lilly buys 4E to beef up its non-opioid pain pipeline
Jun 16, 2026 2:34pm
Lilly’s $2.3B Ajax drug works ‘right out of the gate’
Jun 13, 2026 11:15am